These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1540945)

  • 1. Antibody dependent cell mediated cytotoxicity on human cervical carcinoma cell line, ME-180, with human monoclonal antibody.
    Osumi K; Nagao J; Yuasa H; Fujimoto H; Hagiwara H; Kodera Y; Ohno R
    Cancer Lett; 1992 Feb; 62(2):179-83. PubMed ID: 1540945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
    Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
    J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytolytic activity of murine anti-dog lymphoma monoclonal antibodies with canine effector cells and complement.
    Rosales C; Jeglum KA; Obrocka M; Steplewski Z
    Cell Immunol; 1988 Sep; 115(2):420-8. PubMed ID: 3409330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
    Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
    MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage colony-stimulating factor enhancement of antibody-dependent cellular cytotoxicity against human colon carcinoma cells.
    Qi CF; Nieroda C; De Filippi R; Greiner JW; Correale P; Schlom J; Tsang KY
    Immunol Lett; 1995; 47(1-2):15-24. PubMed ID: 8537095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis.
    Posner MR; Elboim HS; Cannon T; Cavacini L; Hideshima T
    AIDS Res Hum Retroviruses; 1992 May; 8(5):553-8. PubMed ID: 1381201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
    Duchemin M; Khamassi M; Xu L; Tudor D; Bomsel M
    Front Immunol; 2018; 9():244. PubMed ID: 29651286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monocyte-mediated cytotoxicity towards erythrocytes induced by hybrid mouse monoclonal antibodies: effect of antibody binding valency on IgG-Fc gamma R interaction.
    Koolwijk P; Van de Winkel JG; Otten I; Bast BJ
    Immunology; 1992 Feb; 75(2):336-42. PubMed ID: 1532380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies.
    Cheng ZJ; Garvin D; Paguio A; Moravec R; Engel L; Fan F; Surowy T
    J Immunol Methods; 2014 Dec; 414():69-81. PubMed ID: 25086226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent cell-mediated cytotoxicity (ADCC) toward human O+ red cells coated with anti-D antibody: comparison between lymphocyte and monocyte ADCC activity.
    Sunada M; Suzuki S; Ota Z
    Acta Med Okayama; 1985 Apr; 39(2):77-89. PubMed ID: 3923782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon.
    Akiyama Y; Lubeck MD; Steplewski Z; Koprowski H
    Cancer Res; 1984 Nov; 44(11):5127-31. PubMed ID: 6435864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Within peripheral blood mononuclear cells, antibody-dependent cellular cytotoxicity of rituximab-opsonized Daudi cells is promoted by NK cells and inhibited by monocytes due to shaving.
    Beum PV; Lindorfer MA; Taylor RP
    J Immunol; 2008 Aug; 181(4):2916-24. PubMed ID: 18684983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between soluble IgG, complement and cells in lymphocyte and monocyte ADCC.
    Poston RN; Morgan RS
    Immunology; 1983 Nov; 50(3):461-9. PubMed ID: 6629417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-ganglioside GM2 monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes.
    Hanibuchi M; Yano S; Nishioka Y; Yanagawa H; Sone S
    Jpn J Cancer Res; 1996 May; 87(5):497-504. PubMed ID: 8641987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
    Woodhouse CS; Morgan AC
    Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal anti-human tumor antibodies of six isotypes in cytotoxic reactions with human and murine effector cells.
    Herlyn D; Herlyn M; Steplewski Z; Koprowski H
    Cell Immunol; 1985 Apr; 92(1):105-14. PubMed ID: 4075410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of human blood mononuclear cell populations in antibody dependent cellular cytotoxicity (ADCC) using two murine (CO17-1A and Br55-2) and one chimeric (17-1A) monoclonal antibodies against a human colorectal carcinoma cell line (SW948).
    Masucci G; Lindemalm C; Frödin JE; Hagström B; Mellstedt H
    Hybridoma; 1988 Oct; 7(5):429-40. PubMed ID: 3198133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent cell-mediated cytotoxicity using a murine monoclonal antibody against human colorectal cancer in cancer patients.
    Takamuku K; Akiyoshi T; Tsuji H
    Cancer Immunol Immunother; 1987; 25(2):137-40. PubMed ID: 3664531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human IgG2 antibodies against epidermal growth factor receptor effectively trigger antibody-dependent cellular cytotoxicity but, in contrast to IgG1, only by cells of myeloid lineage.
    Schneider-Merck T; Lammerts van Bueren JJ; Berger S; Rossen K; van Berkel PH; Derer S; Beyer T; Lohse S; Bleeker WK; Peipp M; Parren PW; van de Winkel JG; Valerius T; Dechant M
    J Immunol; 2010 Jan; 184(1):512-20. PubMed ID: 19949082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of monoclonal antibody carbohydrates by oxidation, conjugation, or deoxymannojirimycin does not interfere with antibody effector functions.
    Awwad M; Strome PG; Gilman SC; Axelrod HR
    Cancer Immunol Immunother; 1994 Jan; 38(1):23-30. PubMed ID: 8299115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.